Remopharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Remopharma
Largest movements
- Tangible fixed assets +€322,860
up €322,860 (+19.0%), from €1.7m to €2.0m
of which Plant, machinery and equipment: +€290,325
- Receivables within one year +€77,634
up €77,634 (+30.4%), from €255,574 to €333,208
of which Trade receivables: +€80,720
- Current investments -€75,000
down €75,000 (-15.0%), from €501,222 to €426,222
- Cash +€39,114
up €39,114 (+20.2%), from €194,009 to €233,124
mainly Net result for the year (+€241,142) and Depreciation (+€205,996)
- Reserves +€241,142
up €241,142 (+12.3%), from €2.0m to €2.2m
of which Distributable reserves: +€241,142
- Trade debts +€181,473
up €181,473 (+40.6%), from €447,431 to €628,904
- Debts after one year -€86,835
down €86,835 (-12.1%), from €716,145 to €629,311
- Gross operating margin +€136,903
up €136,903 (+14.2%), from €965,347 to €1.1m
- Staff costs +€126,016
up €126,016 (+38.2%), from €329,855 to €455,871
- Financial charges +€50,773
up €50,773 (+82.2%), from €61,768 to €112,541
- Depreciation +€26,702
up €26,702 (+14.9%), from €179,294 to €205,996
- Taxes -€24,839
down €24,839 (-25.1%), from €99,124 to €74,285
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,311,547 | €3,663,433 | +€351,886 | +10.6% |
| Fixed assets | 21/28 | €1,848,006 | €2,145,466 | +€297,460 | +16.1% |
| Intangible fixed assets | 21 | €148,179 | €122,779 | -€25,400 | -17.1% |
| Tangible fixed assets | 22/27 | €1,699,827 | €2,022,687 | +€322,860 | +19.0% |
| Land and buildings | 22 | €1,128,351 | €1,162,576 | +€34,225 | +3.0% |
| Plant, machinery and equipment | 23 | €553,225 | €843,549 | +€290,325 | +52.5% |
| Furniture and vehicles | 24 | €18,252 | €16,562 | -€1,690 | -9.3% |
| Current assets | 29/58 | €1,463,541 | €1,517,967 | +€54,426 | +3.7% |
| Stocks and contracts in progress | 3 | €497,991 | €507,696 | +€9,705 | +1.9% |
| Stocks | 30/36 | €497,991 | €507,696 | +€9,705 | +1.9% |
| Amounts receivable within one year | 40/41 | €255,574 | €333,208 | +€77,634 | +30.4% |
| Trade receivables | 40 | €220,225 | €300,944 | +€80,720 | +36.7% |
| Other amounts receivable | 41 | €35,350 | €32,264 | -€3,086 | -8.7% |
| Current investments | 50/53 | €501,222 | €426,222 | -€75,000 | -15.0% |
| Cash at bank and in hand | 54/58 | €194,009 | €233,124 | +€39,114 | +20.2% |
| Deferred charges and accrued income | 490/1 | €14,745 | €17,718 | +€2,973 | +20.2% |
| Total equity and liabilities | 10/49 | €3,311,547 | €3,663,433 | +€351,886 | +10.6% |
| Equity | 10/15 | €1,964,018 | €2,205,160 | +€241,142 | +12.3% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €1,963,018 | €2,204,160 | +€241,142 | +12.3% |
| Tax-exempt reserves | 132 | €118 | €118 | = | 0.0% |
| Distributable reserves | 133 | €1,962,900 | €2,204,042 | +€241,142 | +12.3% |
| Amounts payable | 17/49 | €1,347,529 | €1,458,273 | +€110,744 | +8.2% |
| Amounts payable after more than one year | 17 | €716,145 | €629,311 | -€86,835 | -12.1% |
| Financial debts | 170/4 | €716,145 | €629,311 | -€86,835 | -12.1% |
| Amounts payable within one year | 42/48 | €629,551 | €827,712 | +€198,161 | +31.5% |
| Current portion of amounts payable after more than one year | 42 | €132,755 | €124,793 | -€7,962 | -6.0% |
| Trade debts | 44 | €447,431 | €628,904 | +€181,473 | +40.6% |
| Suppliers | 440/4 | €447,431 | €628,904 | +€181,473 | +40.6% |
| Taxes, remuneration and social security | 45 | €49,280 | €73,891 | +€24,610 | +49.9% |
| Taxes | 450/3 | €11,003 | €18,138 | +€7,134 | +64.8% |
| Remuneration and social security | 454/9 | €38,277 | €55,753 | +€17,476 | +45.7% |
| Other amounts payable | 47/48 | €85 | €125 | +€40 | +47.1% |
| Accrued charges and deferred income | 492/3 | €1,832 | €1,250 | -€582 | -31.8% |
| Remuneration, social security and pensions | 62 | €329,855 | €455,871 | +€126,016 | +38.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €179,294 | €205,996 | +€26,702 | +14.9% |
| Other operating charges | 640/8 | €14,266 | €24,011 | +€9,745 | +68.3% |
| Gross operating margin | 9900 | €965,347 | €1,102,250 | +€136,903 | +14.2% |
| Operating profit (loss) | 9901 | €441,932 | €416,371 | -€25,561 | -5.8% |
| Financial income | 75/76B | €14,555 | €11,596 | -€2,959 | -20.3% |
| Recurring financial income | 75 | €14,555 | €11,596 | -€2,959 | -20.3% |
| Financial charges | 65/66B | €61,768 | €112,541 | +€50,773 | +82.2% |
| Recurring financial charges | 65 | €61,768 | €112,541 | +€50,773 | +82.2% |
| Profit (loss) for the period before taxes | 9903 | €394,719 | €315,427 | -€79,292 | -20.1% |
| Income taxes | 67/77 | €99,124 | €74,285 | -€24,839 | -25.1% |
| Profit (loss) for the period | 9904 | €295,595 | €241,142 | -€54,453 | -18.4% |
| Profit (loss) for the period to be appropriated | 9905 | €295,595 | €241,142 | -€54,453 | -18.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.